Wingstop Shares Tumble 12 as Earnings Miss Market Expectations
Fanatics Strengthens Position as FIFAs Exclusive Collectibles Licensee Capturing Growing Market Amid Controversy
Fed Rate Cut Prospects Dim as Jobs Report Highlights Sticky Inflation Pressures
CRISPR Therapeutics Releases First Quarter 2026 Results Key Updates on Gene Editing Pipeline
Fidelity to Impose Transaction Fee Up to 100 on Certain ETF Purchases Revealing the Hidden Costs of Custody
Amazon UK Chief Urges Shift in Blaming Youth for Unemployment Points to Education System Gaps
WS Q1 2026 Earnings EPS Falls Short of Estimates Stock Declines
JAGX Q1 2026 Earnings Significant EPS Miss Highlights Operational Challenges
Halozyme Therapeutics Inc HALO Q1 2026 Earnings EPS Surpasses Estimates Despite Flat Revenue Disclosure
BDCI Q1 2026 Earnings Positive EPS of 005 Reported Despite Absence of Revenue Details
VSCO Q1 2026 Earnings Strong EPS Beat Drives Positive Market Response
INVH Q1 2026 Earnings Strong EPS Beat Fails to Boost Sentiment as Stock Edges Lower
Neuronetics STIM Rallies 2 as Shares Test Key Resistance Levels
Ultrapar Participacoes UGP Edges Lower Support Levels Under Scrutiny
Radiopharm Theranostics RADX Holds Steady at 449 Consolidation Phase for Radiopharma Play
Spok Holdings SPOK Edges Lower Testing Support Zone Amid Low Volatility
Catalyst Bancorp Inc CLST Edges Higher in Modest Uptrend
MDXHealth Q1 2026 Earnings EPS Miss Weighs on Shares as Company Navigates Diagnostic Market
enCore Energy Corp EU Q1 2026 Earnings Surprise Profit Driven by Strong Uranium Sales
DPRO Q1 2026 Earnings EPS Misses Estimates by Narrow Margin Stock Gains on Optimism Around Operational Progress
FRSX Q3 2021 Earnings NarrowerThanExpected Loss Drives Positive Market Response
PDLB Q4 2025 Earnings EPS Surges Past Estimates Revenue Details Withheld
CDIO Q1 2025 Earnings Narrowed Loss Beats Estimates Significantly
MarketSmith India Unveils Top Stock Picks for May 27 Session
VREX Q1 2026 Earnings EPS Barely Misses Estimates as Stock Edges Lower
DarkIris Inc DKI Hovers Near Support as Selling Pressure Eases